Herbalife® Nutrition Products, Health & Earnings Claims, and Liver Safety Concerns in Georgia, Public Health Institute of Georgia (PHIG) Position

Date: 25 November 2025

Status: Expert public-health opinion based on independently verifiable scientific and legal sources, including FTC and NIH materials, and PHIG’s own review of Herbalife’s global and Georgian operations

1. Mandate and scope of this statement

The Public Health Institute of Georgia (PHIG) is an independent, non-commercial organization. Our mandate is to:

Protect population health;
Promote evidence-based practice in health, nutrition and weight management;
Support Georgian regulators and consumers in making informed decisions about health-related products and business opportunities.

This statement evaluates Herbalife® Nutrition – a global multi-level marketing (MLM) company selling nutrition and weight-management products – with particular attention to:

the scientific evidence and safety signals for Herbalife’s dietary supplements and meal-replacement products, especially hepatotoxicity (liver injury);
documented misleading health and earnings claims identified by regulators and independent investigators in the United States, Europe and globally, and their implications for Georgia;
Herbalife’s practice of marketing products as being developed or endorsed by a Nobel Prize laureate, without always fully disclosing financial conflicts of interest;
the legal and ethical frameworks that apply to Herbalife’s presence and marketing in Georgia.

This document is not a legal ban and does not replace the authority of Georgian governmental bodies (National Food Agency, State Regulation Agency for Medical Activities, Competition and Consumer Agency, Georgian National Communications Commission, etc.). It is an independent expert risk assessment and policy position directed to:

Consumers in Georgia;
Healthcare professionals;
Regulatory and oversight authorities;
Herbalife distributors, preferred members and logistics partners operating in Georgia.

2. Herbalife® and its products in Georgia

Herbalife Nutrition Ltd. is a global multi-level marketing company founded in 1980 in the United States. It sells weight-management products, protein shakes, vitamin and mineral supplements, herbal tablets, teas and cosmetics through a network of independent distributors in more than 90 countries.^[2,27,31,32]

Herbalife has an official presence in Georgia:

The website Herbalife.ge offers product catalogues and “programmes” for weight loss, balanced nutrition and an active lifestyle, with products sold via “nutrition consultants” (independent distributors).^[1,3,11]
The worldwide address list on Herbalife’s global site lists a Georgian logistics partner “Filuet Georgia” at 3 Teimuraz Bochorishvili Street, Tbilisi, with a toll-free number and email for Georgian customers.^[8]
Herbalife’s Georgian and EU materials classify the products as food supplements and meal replacements, not as medicines, and emphasise direct selling through independent distributors.^{[1,2,3,11,20]}

Main product lines promoted in Georgia include:

Formula 1 meal-replacement shakes for weight management;
High-protein beverages and snack bars for satiety and muscle mass;
Herbal teas and “aloe” drinks marketed for energy and digestion;
Multivitamin and targeted supplements (e.g. heart, joints, skin, “immune system”).^[1,3,11]

These products are marketed as part of personalised weight-management and “healthy lifestyle” programmes – yet legally they remain foods / food supplements, not licensed medicinal products.

3. Scientific evidence and liver safety: what the data actually show

Herbalife often cites internal or sponsored trials showing that its meal-replacement programmes can produce modest weight loss and improvements in some metabolic markers when combined with calorie restriction and professional supervision.^[10,18,31] While such results are plausible and consistent with general evidence on calorie-controlled diets, they do not exempt Herbalife products from scrutiny regarding safety.

In fact, a substantial body of independent medical literature and official toxicology sources document hepatotoxicity (liver injury) associated with Herbalife use:

The US National Institutes of Health LiverTox monograph on Herbalife states that there have been “many reports of acute, clinically apparent liver injury in persons taking Herbalife products” and that at least 50 cases of clinically apparent liver injury have been described worldwide, including cases of acute liver failure and cirrhosis.^[6] LiverTox assigns Herbalife a Likelihood Score: A – meaning a “well established cause of clinically apparent liver injury”.^[6]
The seminal 2007 Israeli case series “Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity” (Elinav et al., J Hepatology) identified an association between intake of Herbalife products and acute hepatitis in multiple patients and called for prospective evaluation of Herbalife for possible hepatotoxicity, recommending caution especially in people with underlying liver disease.^[29]
Subsequent case series from Spain, Switzerland, Iceland, Argentina, Venezuela and other countries reported dozens more cases of liver injury temporally linked to Herbalife consumption, including severe cases requiring liver transplantation and at least one reported fatality.^{[6,10,13,14,20,23,25,29]}
A 2019 case report “Herbalife® Associated Severe Hepatotoxicity in a Previously Healthy Woman” described acute liver damage highly suspected to be due to Herbalife products, after exclusion of other causes; the authors noted that more than 50 cases of Herbalife-associated liver injury had been reported in the literature, ranging from mild enzyme elevations to fulminant hepatitis requiring transplantation.^[3,21]
Reviews of herb-induced liver injury (HILI) repeatedly cite Herbalife as a well-documented example of a multi-ingredient supplement line associated with hepatotoxicity, with causality in many cases rated as “probable” or “certain” using standard scoring systems (e.g. RUCAM, WHO criteria).^{[6,8,13,25,26,29,39]}

These findings have important implications:

They do not prove that Herbalife products will cause liver damage in every user, but they demonstrate that Herbalife is a recognised cause of clinically apparent, and sometimes severe, liver injury in susceptible individuals.^[6]
Long-term, unsupervised use of complex, multi-ingredient Herbalife regimens – especially for weight loss – carries non-trivial safety risks, particularly for people with existing liver disease, those taking other hepatotoxic drugs, or those using many different Herbalife products simultaneously.^[6,21,23,29]

Notably, Herbalife’s own public FAQ titled “Can Herbalife products cause liver damage?” states: “No, Herbalife products do not cause liver damage… There has never been any conclusive evidence of connections between any of our products, ingredients, and liver disease.”^[17] This corporate statement stands in stark contrast to the NIH LiverTox assessment (Likelihood score A; “well established cause”) and the extensive peer-reviewed case literature cited above.

4. Global misleading claims: health, income, and Nobel branding

4.1. FTC findings on Herbalife’s misleading moneymaking claims

In 2016, the US Federal Trade Commission (FTC) brought a landmark case against Herbalife, alleging that its business opportunity claims were deceptive. According to the FTC’s Business Blog post “It’s no longer business as usual at Herbalife”, the agency concluded that:^[3,4,31]

Herbalife advertised in English and Spanish that people could “quit their jobs and make the big bucks” and take their families on vacations thanks to Herbalife income;^[3]
In reality, the FTC’s analysis showed that half of Herbalife “Sales Leaders” earned on average less than $5 per month from product sales;
For those who invested heavily to open so-called “Nutrition Clubs” (brick-and-mortar outlets), the majority made no money or actually lost money;^[3]
The FTC alleged that the small minority who did earn substantial income did so primarily by recruiting other distributors – encouraging them to buy Herbalife products – rather than by selling products to genuine retail customers;^[3]
The FTC complaint charged that this model of incentivising recruitment and internal consumption, rather than genuine retail demand, was an unfair practice in violation of the FTC Act.^[3,4]

Under the 2016 settlement and order:

Herbalife agreed to pay $200 million to provide refunds to distributors who lost money based on misleading income claims;^[4,31]
Herbalife was required to fundamentally restructure its US business from top to bottom – moving away from rewarding recruitment and internal consumption, and towards compensating verifiable retail sales to real customers;^[3,4]
At least two-thirds of distributor rewards now must be based on documented retail sales, with no more than one-third from personal consumption, and 80% of net sales must be real sales to real buyers or high-level rewards are reduced;^[3]
An Independent Compliance Auditor must monitor Herbalife’s adherence to the new compensation system for seven years.^[3,4]

Although the FTC case focused on the United States, the practices it addressed – inflated income claims, over-reliance on recruitment, and misrepresentation of business opportunity – are highly relevant warnings for regulators and consumers in Georgia and other markets where Herbalife operates under a similar MLM structure.

4.2. Nobel Prize branding and undisclosed conflicts of interest

Herbalife has heavily marketed its cardiovascular supplement Niteworks® as being based on the research of Dr Louis J. Ignarro, a pharmacologist who received the 1998 Nobel Prize in Physiology or Medicine for his work on nitric oxide. For example, a Herbalife press release about a Niteworks study states that “Niteworks was created based on research conducted by Lou Ignarro, Ph.D., who received the Nobel Prize in 1998 for his work on nitric oxide” and notes that Ignarro is a member of Herbalife’s Scientific and Nutrition Advisory Boards.^[7,21,24,26]

However, the broader history of this relationship raises important ethical and reputational concerns:

Investigative reporting by Bloomberg and the Los Angeles Times in 2004 revealed that Ignarro had a for Niteworks, through which his consulting company received at least $1 million in the first 12 months of sales (and later more than $15 million overall), while he promoted the product’s ingredients in a scientific journal paper without initially disclosing this financial interest.^{[0,2,6,9,11,16,22]}
The Proceedings of the National Academy of Sciences (PNAS) subsequently published an erratum stating that the authors should have disclosed that Ignarro “developed and markets Niteworks” and that he was a member of the Scientific Advisory Board of Herbalife, the distributor of Niteworks.^[0,5,10]
Ethics commentators and media outlets (e.g. Washington Post, Columbia Journalism Review, Retraction Watch, For Better Science) have criticised this episode as a clear conflict of interest, in which a Nobel laureate’s academic work and reputation were leveraged to market a commercial supplement, while the full extent of his financial ties was not transparently disclosed at the time of publication.^{[5,10,14,21,22]}

PHIG’s concern is not about Ignarro’s Nobel Prize itself, but about how Herbalife has used the “Nobel Prize-winner developed this product” narrative in marketing, often without equally prominent disclosure of:

the limited and specific nature of the scientific evidence supporting Niteworks’ claimed benefits;
the substantial royalty arrangements and long-term commercial partnership between Herbalife and Ignarro;^[7,9,16,21]
the existence of published corrections and ethical controversy around the original research publications linked to Niteworks.^[0,5,10,22]

From a public-health and ethics perspective, this pattern illustrates how scientific prestige can be selectively used to oversell product benefits, while conflicts of interest and uncertainties are downplayed.

5. PHIG’s assessment of Herbalife’s presence and risks in Georgia

Herbalife’s structured presence in Georgia (via Herbalife.ge and Filuet Georgia) means that:

Weight-loss and wellness products with documented, albeit rare, hepatotoxicity risks are being promoted locally through MLM networks;^{[1,3,6,21,23,29]}
The same MLM dynamics that led to misleading income claims and consumer harm in the US, as found by the FTC, may arise in Georgia if not actively monitored and regulated;^[3,4,7]
Consumers may be exposed to inflated health claims (e.g. “detox”, “cleansing the liver”, “treating obesity or diabetes”) that extend beyond EU- and Georgia-compliant food supplement claims.

PHIG has received anecdotal reports of Georgian distributors portraying Herbalife shakes and teas as quasi-medical solutions for obesity, “fatty liver”, and “sugar problems”, sometimes accompanied by testimonials rather than robust evidence. While PHIG has not yet completed a systematic content audit of Herbalife’s Georgian marketing, the global pattern of such claims – and Herbalife’s own history of having to discipline hundreds of distributors for improper medical claims – justifies heightened scrutiny.^[6,9,14,16]

6. Regulatory frameworks and legal concerns

6.1. Georgia

The Law of Georgia on Advertising regulates all advertising in goods and services markets, with the aim of developing fair competition, protecting public interests and consumer rights, and preventing and eliminating improper advertising.^{[3,7,18,19,22,26]}

Under this law:

Advertising must be truthful, clear and not misleading;
Deceptive and hidden advertising is prohibited;
Responsibility for violations may fall on advertisers, producers and disseminators; the Georgian National Communications Commission (GNCC) can act against improper broadcast advertising and covert marketing.^{[7,15,18,22,37]}

If Herbalife distributors in Georgia:

represent Herbalife products as treatments or cures for specific diseases (e.g. diabetes, liver disease, cancer); or
make unrealistic earnings claims about joining Herbalife as a business opportunity;

such behaviour would be incompatible with Georgian advertising and consumer-protection standards and should trigger regulatory review.

6.2. European Union

In the EU, where Herbalife has a significant presence, Regulation (EC) No 1924/2006 on nutrition and health claims provides that:^[2,11,27,32]

Only authorised health claims may be used on foods and supplements; they must be specific, scientifically substantiated and not misleading;
Claims that a food “prevents, treats or cures disease” are prohibited and reserved for authorised medicinal products under Directive 2001/83/EC;
Herbalife’s own filings acknowledge that EU health-claim regulation has required it to adapt its labelling and marketing and that non-compliance could adversely affect business.^[2,11]

These EU rules are a useful benchmark for Georgia, which is aligning many of its food-safety and consumer-protection norms with European standards.

6.3. United States

Under US law (DSHEA; FDA and FTC guidance), dietary supplements:

may not be marketed as drugs or as cures for specific diseases without prior FDA approval as new drugs;^{[5–7,23,26]}
must have health-related statements supported by “competent and reliable scientific evidence”; unsubstantiated claims can lead to enforcement action.

The 2016 FTC settlement with Herbalife illustrates that MLM companies can face substantial financial and structural remedies when their earnings claims and business practices are deceptive.^{[3,4,7,12,28,33]} Similarly, Herbalife’s repeated challenges to the medical literature on its liver safety (e.g. letters contesting case reports) highlight the need for independent, not sponsor-driven, evaluation of harms.^[6,25,27]

7. PHIG’s official position on Herbalife® products in Georgia

7.1. Non-recommendation as medical treatment or stand-alone weight-loss solution

Taking into account the totality of evidence, PHIG adopts the following position as of 25 November 2025:

PHIG does not recommend the use of Herbalife® products as medical treatments for any disease (including obesity, diabetes, liver disease, cancer, autism, epilepsy or cardiovascular disease), nor as a stand-alone solution for weight loss in Georgia.

More specifically:

Herbalife products should be considered, at most, as commercial food supplements or meal replacements, not as medicines.
Any short-term weight-loss benefits from calorie-restricted meal replacements do not justify long-term, unsupervised use or substitution for lifestyle change and evidence-based medical care.
Individuals with liver disease, metabolic conditions or multiple medications should be particularly cautious and consult a physician before using Herbalife products, given the recognised – albeit rare – risk of serious liver injury.^{[1,3,6,13,21,23,25,29,34,37,39]}
PHIG strongly discourages aggressive “transformation” or “detox” programmes built around multiple Herbalife products, especially when guided solely by commercial distributors without medical training.

7.2. Guidance for healthcare professionals and consumers

PHIG recommends that healthcare professionals in Georgia:

Routinely ask patients about the use of Herbalife and other weight-loss or herbal supplements, particularly in cases of unexplained liver dysfunction, fatigue or gastrointestinal symptoms;
Inform patients that independent toxicology sources (e.g. NIH LiverTox) classify Herbalife as a well-established cause of clinically apparent liver injury, despite the company’s public denials;^[6,17]
Advise that Herbalife products should never replace prescribed medications or evidence-based therapies for chronic diseases.

PHIG encourages consumers:

To view Herbalife products as ordinary commercial supplements, not as miracle cures or medical treatments;
To be wary of distributors who claim that Herbalife can “cure” diseases or guarantee high income – such statements conflict both with Herbalife’s own formal policies and with Georgian and international law;^{[3,4,6,9,14,16,19,22]}
To seek independent information in Georgian from platforms such as SheniEkimi.ge, SheniAmbebi.ge and Supplement.ge.

8. Recommendations to Georgian regulators

8.1. National Food Agency and health regulators

Systematically review the registration, labelling, composition and safety data of Herbalife products marketed in Georgia, with particular attention to ingredients and combinations associated with hepatotoxicity or other serious adverse effects;
Ensure that all Herbalife products comply with Georgian and EU-aligned standards for food supplements and meal replacements, including maximum levels for certain nutrients and absence of undeclared pharmacologically active substances.

8.2. Competition and Consumer Agency

Monitor Herbalife-related marketing in Georgia – especially online and social media – for potential violations of the Law of Georgia on Advertising, focusing on disease-treatment claims and exaggerated earnings promises;
Issue guidance and, where necessary, impose sanctions or corrective measures against misleading or unfair advertising by Herbalife distributors.

8.3. Georgian National Communications Commission (GNCC)

Review broadcast and digital content where Herbalife products are featured, to identify covert marketing or disguised health advice that may mislead viewers or listeners;
Coordinate with other regulatory bodies to address problematic MLM advertising patterns in the health and wellness sector.

9. Legal and evidentiary robustness of PHIG’s position

PHIG’s position is grounded in:

Herbalife’s own filings and policies, including SEC reports that acknowledge EU health-claim constraints, and “Rules of Conduct” that formally prohibit distributors from making disease or medical claims and require legal compliance;^[2,11,16,32]
Regulatory actions and official analyses, notably the 2016 FTC settlement and detailed Business Blog, which describe Herbalife’s obligation to pay $200 million in consumer redress and to fundamentally restructure its compensation system to curb misleading earnings claims;^{[3,4,7,12,28,31,33]}
Independent toxicology and clinical literature, including the NIH LiverTox monograph and multiple peer-reviewed case reports and reviews documenting at least 50 cases of clinically apparent liver injury linked to Herbalife products, some severe or fatal;^{[1,3,6,8,10,13,14,20,21,23,25,26,29,34,37,39]}
Investigations into Nobel branding and conflicts of interest, documenting how Nobel laureate Louis Ignarro’s financial ties to Herbalife and Niteworks royalties were initially undisclosed in key scientific publications, leading to errata and public criticism;^{[0,5,6,7,9,10,11,14,16,21,22]}
Herbalife’s official FAQ statements, which deny any evidence of a connection between its products and liver disease, in stark contrast to LiverTox’s “Likelihood score A” classification and the published hepatotoxicity literature;^[6,17]
Georgian, EU and US legal frameworks on advertising, dietary supplements and MLM schemes, which collectively prohibit unsubstantiated disease-treatment and earnings claims and require truthful, non-misleading marketing practices.^{[3,5–7,10,11,15,18,19,22,26,27,32,36,37]}

PHIG does not claim that Herbalife products are unsafe for all users or that every Georgian distributor acts unlawfully. However, the converging evidence of:

documented hepatotoxicity signals;
a history of misleading income and, in some cases, health claims at the global level;
the ethical issues surrounding Nobel-branded products and undisclosed conflicts of interest;
the structural vulnerabilities inherent in MLM models;

provides sufficient grounds, under the precautionary principle and consumer-protection norms, for PHIG to issue this public non-recommendation and to call for continued regulatory vigilance regarding Herbalife’s marketing and operations in Georgia.

Sources (Vancouver style)

Herbalife Georgia. Herbalife.ge – Official Georgian site [Internet]. Tbilisi (GE): Herbalife; c2025 [cited 2025 Nov 25]. Available from: https://www.herbalife.ge
Herbalife Ltd. Form 10-K Annual Report [Internet]. Los Angeles (CA): Herbalife; 2007 [cited 2025 Nov 25]. Available from: https://ir.herbalife.com/sec-filings
Herbalife Georgia. Products and Programmes [Internet]. Tbilisi (GE): Herbalife; c2025 [cited 2025 Nov 25]. Available from: https://www.herbalife.ge/catalog/
Fair L. It’s no longer business as usual at Herbalife: An inside look at the $200 million FTC settlement [Internet]. Washington (DC): Federal Trade Commission Business Blog; 2016 Jul 15 [cited 2025 Nov 25]. Available from: https://www.ftc.gov/business-guidance/blog/2016/07/its-no-longer-business-usual-herbalife-inside-look-200-million-ftc-settlement
US Food and Drug Administration. Dietary Supplements – Guidance and Compliance [Internet]. Silver Spring (MD): FDA; 2017–2024 [cited 2025 Nov 25]. Available from: https://www.fda.gov/food/dietary-supplements
LiverTox. Herbalife [Internet]. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2018 Apr 11 [cited 2025 Nov 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548447/
Federal Trade Commission. Herbalife Will Restructure Its Multi-level Marketing Operations and Pay $200 Million For Consumer Redress [Internet]. 2016 Jul 15 [cited 2025 Nov 25]. Available from: https://www.ftc.gov/news-events/news/press-releases/2016/07/herbalife-will-restructure-its-multi-level-marketing-operations-pay-200-million-consumer-redress
Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol. 2015;89(6):851–865.
Louis Ignarro. Louis J. Ignarro – Biography and Herbalife relationship [Internet]. LA Business Journal; 2005 Jan 10 [cited 2025 Nov 25].
Retraction Watch. What should journals do when peer reviewers do not disclose potential conflicts? [Internet]. 2017 Aug 15 [cited 2025 Nov 25]. Available from: https://retractionwatch.com/2017/08/15/journals-peer-reviewers-not-disclose-potential-conflicts/
Herbalife Nutrition. European Health Claims and Product Labelling. SEC filing 0000950124-08-000865 [Internet]. 2008 [cited 2025 Nov 25].
FTC. Herbalife International of America, Inc., et al. – Case 142-3037 [Internet]. Washington (DC): Federal Trade Commission; 2016 [cited 2025 Nov 25]. Available from: https://www.ftc.gov/legal-library/browse/cases-proceedings/142-3037-herbalife-international-america-inc-et-al
Seeff LB, Bonkovsky HL, Navarro VJ, Wang G. Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology. 2015;148(3):517–532.
Columbia Journalism Review. Commercialization of the academy: diet supplements edition [Internet]. 2013 Feb 27 [cited 2025 Nov 25]. Available from: https://www.cjr.org/the_audit/herbalife_and_hiltzik.php
Transparency International Georgia. The Georgian Advertising Market [Internet]. Tbilisi (GE); 2011 Dec 19 [cited 2025 Nov 25].
Herbalife Nutrition EMEA. Rules of Conduct – Distributors [Internet]. 2025 Aug 10 [cited 2025 Nov 25]. Available from: https://assets.herbalifenutrition.com/content/dam/regional/emea/ka_ge/consumable_content/policy-and-compliance/Rules_of_Conduct_en-GE.pdf
Herbalife. Can Herbalife products cause liver damage? [Internet]. Herbalife FAQ; 2023 [cited 2025 Nov 25]. Available from: https://www.herbalife.com/en-gh/frequently-asked-questions/can-herbalife-products-cause-liver-damage
Li Z, et al. Weight loss with a high-protein meal replacement program. ClinTrials.gov Identifier: NCT02144636 [Internet]. 2010–2014 [cited 2025 Nov 25].
Parliament of Georgia. Law of Georgia on Advertising [Internet]. 1998 Feb 18 [cited 2025 Nov 25]. Available from: https://assets.tobaccocontrollaws.org/uploads/legislation/Georgia/Georgia-Law-on-Advertising.pdf
Herbalife Nutrition. Frequently Asked Questions – Product Safety [Internet]. 2023 [cited 2025 Nov 25].
Jurčić D, et al. Herbalife® associated severe hepatotoxicity in a previously healthy woman. World J Clin Cases. 2019;7(12):1544–1553. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7314303/
Zambrone FAD, et al. A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife® products. Braz J Pharm Sci. 2015;51(1):1–14.
Chao S, et al. Toxic hepatitis by consumption of Herbalife® products. Rev Esp Enferm Dig. 2008;100(10):611–615.
Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis. 2014;34(2):172–193.
Rossi S, Navarro VJ. Herbs and liver injury: a clinical perspective. Clin Gastroenterol Hepatol. 2014;12(7):1069–1076.
US NIH DILIN. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology. 2015;148(7):1340–1352.
NIHR Evidence. Resveratrol supplements do not improve cardiovascular risk markers [Internet]. 2015 Aug 21 [cited 2025 Nov 25]. Available from: https://evidence.nihr.ac.uk/alert/resveratrol-supplements-do-not-improve-cardiovascular-risk-markers/
Elinav E, et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol. 2007;47(4):514–520.
Herbalife Nutrition. Niteworks proven effective in clinical study [Internet]. 2010 Apr 6 [cited 2025 Nov 25]. Available from: https://ir.herbalife.com/news-events/press-releases/detail/567/herbalifes-niteworks-proven-effective-in-clinical-study
Evans D. Nobel laureate’s ties to product are criticized. Bloomberg News / Houston Chronicle [Internet]. 2004 Dec 9 [cited 2025 Nov 25].
Washington Post. Nitric oxide now – ask me how. 2003 Oct 6.
Lilienfeld SO. Nobelists gone wild. In: Science and Pseudoscience in Clinical Psychology. 2018.
For Better Science. Fake data and real pomegranate juice in Nobelist Louis Ignarro’s papers [Internet]. 2018 Aug 27.
GNCC. Regulation of Broadcast Advertising [Internet]. Tbilisi (GE); 2015.
Ballotin VR, et al. Herb-induced liver injury: systematic review and meta-analysis. World J Clin Cases. 2021;9(20):5508–5527.
Navarro VJ, Seeff LB. Liver injury induced by herbals and dietary supplements. Clin Liver Dis. 2013;17(4):715–735.